Zdrowie i gospodarka · 30/03/1994
Opportunity for a License: Identification of a Suppressor of Atherogenic Apolipoprotein
The National Institutes of Health is seeking a licensee for a new invention that identifies a genetic sequence suppressing apolipoprotein B transcription, which is linked to cardiovascular disease.